CATX Price / Book | PERSPECTIVE THERAPEUTICS, INC.

Perspective Therapeutics, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Perspective Therapeutics, Inc. price/book ratio for the quarter ending 2026-06-30 was 1.2, a 24.21% increase year-over-year.
Perspective Therapeutics, Inc. price/book ratio for the quarter ending 2026-03-31 was 1.37, a 146.96% increase year-over-year.
Perspective Therapeutics, Inc. price/book ratio for the quarter ending 2025-12-31 was 0.99, a 27.08% increase year-over-year.
Perspective Therapeutics, Inc. price/book ratio for the quarter ending 2025-09-30 was 1.06, a 61.38% decline year-over-year.
Perspective Therapeutics, Inc. price/book ratio for fiscal 2026 was 1.2.
Perspective Therapeutics, Inc. price/book ratio for fiscal 2025 was 0.99, a 27.08% increase from fiscal 2024.
Perspective Therapeutics, Inc. price/book ratio for fiscal 2024 was 0.78, a 48.27% decline from fiscal 2023.
Perspective Therapeutics, Inc. price/book ratio for fiscal 2023 was 1.5, a 76.94% decline from fiscal 2022.

Available history: 2011-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.2	$388.46M	$323.86M
2026-03-31	1.37	$475.45M	$347.44M
2025-12-31	0.99	$204.06M	$207.03M
2025-09-30	1.06	$256.84M	$242.22M
2025-06-30	0.97	$256.58M	$265.69M
2025-03-31	0.55	$157.73M	$284.65M
2024-12-31	0.78	$225.44M	$290.67M
2024-09-30	2.75	$901.96M	$328.47M
2024-06-30	1.97	$672.23M	$341M
2024-03-31	30.38	$6.98B	$229.89M
2023-12-31	1.5	$112.72M	$75.18M
2023-09-30	7.67	$757.54M	$98.77M
2023-06-30	17.3	$1.88B	$108.65M
2023-03-31	15.11	$1.78B	$118.03M
2022-12-31	6.5	$355.28M	$54.64M
2022-09-30	5.66	$326.86M	$57.7M
2022-06-30	7.19	$440.32M	$61.28M
2022-03-31	8.09	$511.34M	$63.2M
2021-12-31	8.6	$553.96M	$64.39M
2021-09-30	13.6	$894.07M	$65.76M
2021-06-30	16.84	$1.14B	$67.41M
2021-03-31	22.64	$1.54B	$68.1M
2020-12-31	30.73	$392.55M	$12.77M
2020-09-30	78.43	$399.61M	$5.1M
2020-06-30	67.42	$385.83M	$5.72M
2020-03-31	61.63	$358.55M	$5.82M
2019-12-31	68.04	$417.81M	$6.14M
2019-09-30	31.01	$215.64M	$6.96M
2019-06-30	35.98	$276.29M	$7.68M
2019-03-31	28.93	$249.15M	$8.61M
2018-12-31	20.9	$201.99M	$9.67M
2018-09-30	31.52	$350.12M	$11.11M
2018-06-30	50.4	$253.49M	$5.03M
2018-03-31	34.98	$231.42M	$6.62M
2017-12-31	28	$220.4M	$7.87M
2017-09-30	31.28	$286.09M	$9.15M
2017-06-30	32.69	$346.61M	$10.6M
2017-03-31	26.5	$324.6M	$12.25M
2016-12-31	23.52	$319.1M	$13.57M
2016-09-30	26.45	$396.08M	$14.97M
2016-06-30	29.18	$478.59M	$16.4M
2016-03-31	28.25	$495.1M	$17.52M
2015-12-31	27.88	$517.13M	$18.55M
2015-09-30	38.82	$770.19M	$19.84M
2015-06-30	39.15	$813.52M	$20.78M
2015-03-31	39.9	$861.68M	$21.6M
2014-12-31	24.9	$560.92M	$22.53M
2014-09-30	39.6	$927.53M	$23.42M
2014-06-30	71.24	$1.71B	$23.96M
2014-03-31	48.35	$1.19B	$24.65M
2013-12-31	29.6	$192.1M	$6.49M
2013-09-30	34.72	$257.41M	$7.41M
2013-06-30	30.97	$166.17M	$5.37M
2013-03-31	29.5	$186.9M	$6.34M
2012-12-31	38.44	$269.97M	$7.02M
2012-09-30	30.55	$249.1M	$8.16M
2012-06-30	53.73	$312.6M	$5.82M
2012-03-31	22.88	$140.72M	$6.15M
2011-12-31	28.98	$193.49M	$6.68M
2011-09-30	48.36	$262.28M	$5.42M
2011-06-30	38.52	$248.57M	$6.45M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.2	$388.46M	$323.86M
2025-12-31	0.99	$204.06M	$207.03M
2024-12-31	0.78	$225.44M	$290.67M
2023-12-31	1.5	$112.72M	$75.18M
2022-12-31	6.5	$355.28M	$54.64M
2021-12-31	8.6	$553.96M	$64.39M
2020-12-31	30.73	$392.55M	$12.77M
2019-12-31	68.04	$417.81M	$6.14M
2018-12-31	20.9	$201.99M	$9.67M
2017-12-31	28	$220.4M	$7.87M
2016-12-31	23.52	$319.1M	$13.57M
2015-12-31	27.88	$517.13M	$18.55M
2014-12-31	24.9	$560.92M	$22.53M
2013-12-31	29.6	$192.1M	$6.49M
2012-12-31	38.44	$269.97M	$7.02M
2011-12-31	28.98	$193.49M	$6.68M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Upstream Bio, Inc. (UPB)	United States	$0.284B	-2.42
Contineum Therapeutics, Inc. (CTNM)	United States	$0.289B	-4.40
Sagimet Biosciences Inc. (SGMT)	United States	$0.279B
Fulcrum Therapeutics, Inc. (FULC)	United States	$0.289B	-3.28
ROCKET PHARMACEUTICALS, INC. (RCKT)	United States	$0.296B	-21.78
STANDARD BIOTOOLS INC. (LAB)	United States	$0.297B	3.80
Mereo BioPharma Group plc (MREO)		$0.269B	-9.41
Vanda Pharmaceuticals Inc. (VNDA)	United States	$0.302B	-1.35
Greenwich LifeSciences, Inc. (GLSI)	United States	$0.267B	-15.02
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58